Insider · CIK 0001503062

Patel Sunil

Reports to the SEC for 3 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001503062

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-23	OABIWOmniAb, Inc. · Restricted Stock UnitsA Award	Director	AAward	+20K sh	—	—	20,000
2023-06-23	OABIWOmniAb, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-01-30	OABIWOmniAb, Inc.A Award	Director	AAward	+8,753 sh	—	—	224,265
2023-01-30	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+37.8K sh	—	—	37,840
2022-11-09	OABIWOmniAb, Inc.P Purchase	Director	PPurchase	+43K sh	$2.77	+$119K	215,512
2022-11-01	LGNDLIGAND PHARMACEUTICALS INCD Disposition to Issuer	Former Director	DDisposition to Issuer	−1,004 sh	—	—	28,820
2022-11-01	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−4,340 sh	—	—	0
2022-11-01	OABIWOmniAb, Inc.A Award	Director	AAward	+173K sh	—	—	172,512
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+14.2K sh	—	—	14,178
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+11.8K sh	—	—	11,789
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+9,970 sh	—	—	9,970
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+10.5K sh	—	—	10,513
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+10.6K sh	—	—	10,590
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+17.4K sh	—	—	17,427
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+10.6K sh	—	—	10,565
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+14K sh	—	—	13,994
2022-11-01	OABIWOmniAb, Inc. · Stock OptionA Award	Director	AAward	+37.8K sh	—	—	37,840
2022-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Former Director	AAward	+1,004 sh	—	—	29,824
2022-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+4,340 sh	—	—	4,340
2021-06-04	LGNDLIGAND PHARMACEUTICALS INCA Award	Former Director	AAward	+630 sh	—	—	28,820
2021-06-04	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+3,269 sh	—	—	3,269
2020-11-02	LGNDLIGAND PHARMACEUTICALS INCP Purchase	Former Director	PPurchase	+1,000 sh	$82.52	+$82.5K	28,190
2020-06-10	LGNDLIGAND PHARMACEUTICALS INCA Award	Former Director	AAward	+831 sh	—	—	27,190
2020-06-10	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+2,468 sh	—	—	2,468
2019-08-02	LGNDLIGAND PHARMACEUTICALS INCP Purchase	Former Director	PPurchase	+1,000 sh	$95.98	+$96K	26,359
2019-06-06	LGNDLIGAND PHARMACEUTICALS INCA Award	Former Director	AAward	+835 sh	—	—	25,359
2019-06-06	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+4,071 sh	—	—	4,071
2018-08-16	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+5,000 sh	$9.60	+$48K	44,806
2018-08-16	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+7,335 sh	$10.12	+$74.2K	52,141
2018-08-16	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+7,335 sh	$12.53	+$91.9K	59,476
2018-08-16	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	Former Director	MExercise/Conversion	+7,335 sh	$32.30	+$237K	66,811
2018-08-16	LGNDLIGAND PHARMACEUTICALS INCS Sale	Former Director	SSale	−42.3K sh	$240.05	−$10.2M	24,524
2018-08-16	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−5,000 sh	—	—	0
2018-08-16	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−7,335 sh	—	—	0
2018-08-16	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−7,335 sh	—	—	0
2018-08-16	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Former Director	MExercise/Conversion	−7,335 sh	—	—	0
2018-06-19	LGNDLIGAND PHARMACEUTICALS INCA Award	Former Director	AAward	+493 sh	—	—	39,806
2018-06-19	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+2,474 sh	—	—	2,474
2018-06-19	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+2,474 sh	—	—	2,474
2017-10-10	OncoMed Pharmaceuticals IncS Sale	See Remarks	SSale	−46 sh	$4.27	−$196.42	69,538
2017-10-10	OncoMed Pharmaceuticals IncS Sale	See Remarks	SSale	−1,202 sh	$4.24	−$5,098.644	68,336
2017-10-07	OncoMed Pharmaceuticals IncA Award	See Remarks	AAward	+25K sh	—	—	69,584
2017-10-07	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	See Remarks	AAward	+50K sh	—	—	50,000
2017-05-25	LGNDLIGAND PHARMACEUTICALS INCA Award	Former Director	AAward	+666 sh	—	—	39,313
2017-05-25	LGNDLIGAND PHARMACEUTICALS INC · Non-Qualified Stock Option (right to buy)A Award	Former Director	AAward	+2,456 sh	$113.50	+$279K	2,456
2017-04-23	OncoMed Pharmaceuticals IncA Award	See Remarks	AAward	+20K sh	—	—	44,584
2017-04-23	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	See Remarks	AAward	+60K sh	—	—	60,000
2017-04-04	OncoMed Pharmaceuticals IncS Sale	See Remarks	SSale	−43 sh	$8.87	−$381.595	30,295
2017-04-04	OncoMed Pharmaceuticals IncS Sale	See Remarks	SSale	−5,711 sh	$9.06	−$51.7K	24,584
2017-01-03	OncoMed Pharmaceuticals IncStock Option (Right to Buy)A Award	See Remarks	AAward	+65K sh	—	—	65,000

Recent filings

Accepted (ET)
Jun 274
Patel Sunil0001846253-23-000086
SEC(opens sec.gov)
Feb 14
Patel Sunil0001846253-23-000012
SEC(opens sec.gov)
Nov 104
Patel Sunil0000899243-22-035565
SEC(opens sec.gov)
Nov 34
Patel Sunil0000899243-22-035058
SEC(opens sec.gov)
Nov 34
Patel Sunil0000899243-22-035039
SEC(opens sec.gov)
Jun 134
Patel Sunil0000886163-22-000078
SEC(opens sec.gov)
Jun 74
Patel Sunil0000886163-21-000088
SEC(opens sec.gov)

Companies

Address

1277 ROSE AVENUE

MOUNTAIN VIEW, CA, 94040